Sheel Biotech Share Price & Earnings Call Analysis
₹56.65-3.49% today
- Market cap
- ₹115 Cr
- P/E
- 9.77
- ROE
- 11.19%
- PEG
- 0.30
- Price to sales
- 1.05
- Debt to equity
- 0.07
- 52W high / low
- ₹81.0 / ₹39.0
- Sales growth (5Y)
- 11.80%
- EBITDA margin
- 14.84%
- Net profit margin
- 10.73%
- Promoter holding
- 72.31%
- Sales (last year)
- ₹110 Cr
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Financials of Sheel Biotech
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Sheel Biotech
Quarterly Results
Quarter-by-quarter operating performance
No quarterly results data available for this company yet.
Financials of Sheel Biotech
Profit & Loss
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 63 | 84 | 89 | 103 | 110 | 110 |
| Expenses + | 56 | 78 | 80 | 89 | 95 | 94 |
| Operating Profit | 7 | 6 | 9 | 14 | 15 | 16 |
| OPM % | 10% | 8% | 10% | 14% | 14% | 15% |
| Other Income + | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 5 | 5 | 6 | 12 | 13 | 14 |
| Tax % | 0% | 2% | 20% | 15% | 17% | 16% |
| Net Profit + | 5 | 5 | 5 | 10 | 11 | 12 |
| EPS in Rs | 11.58 | 10.88 | 12.26 | 25.27 | 7.12 | 5.78 |
| Dividend Payout % | 0% | 28% | 25% | 12% | 14% | 0% |
Financials of Sheel Biotech
Balance Sheet
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 15 | 15 |
| Reserves | 53 | 56 | 59 | 69 | 69 | 69 |
| Borrowings + | 21 | 24 | 19 | 24 | 17 | 27 |
| Other Liabilities + | 4 | 10 | 11 | 10 | 12 | 13 |
| Total Liabilities | 82 | 93 | 94 | 106 | 113 | 124 |
| Fixed Assets + | 8 | 8 | 8 | 7 | 7 | 7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 |
| Other Assets + | 75 | 84 | 85 | 98 | 105 | 116 |
| Total Assets | 82 | 93 | 94 | 106 | 113 | 124 |
Financials of Sheel Biotech
Cash Flows
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 2 | 9 | -1 | 9 | ||
| Cash from Investing Activity + | -2 | -2 | -0 | -2 | ||
| Cash from Financing Activity + | -0 | -7 | 2 | -7 | ||
| Net Cash Flow | -0 | -0 | 0 | -0 | ||
| Free Cash Flow | 1 | 8 | -1 | 8 | ||
| CFO/OP | 37% | 105% | 3% | 75% |
Financials of Sheel Biotech
Ratios
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 352 | 280 | 230 | 204 | 182 | |
| Inventory Days | 55 | 120 | 177 | 263 | 272 | |
| Days Payable | 30 | 85 | 75 | 37 | 29 | |
| Cash Conversion Cycle | 377 | 315 | 332 | 430 | 426 | |
| Working Capital Days | 348 | 274 | 255 | 256 | 253 | |
| ROCE % | 7% | 10% | 15% | 14% |